# Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus

> **NCT00762736** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 704 (actual)

## Conditions studied

- Diabetes Mellitus

## Interventions

- **DRUG:** Pioglitazone and azilsartan
- **DRUG:** Pioglitazone and azilsartan
- **DRUG:** Pioglitazone
- **DRUG:** Pioglitazone and azilsartan
- **DRUG:** Pioglitazone and azilsartan
- **DRUG:** Pioglitazone

## Key facts

- **NCT ID:** NCT00762736
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2005-10
- **Final completion:** 2005-10
- **Target enrollment:** 704 (ACTUAL)
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00762736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00762736, "Efficacy and Safety of Pioglitazone and Azilsartan in Treating Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00762736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*